PMCPA Case
| Case | AUTH/2421/7/11 (PDF refers to CASE AUTH/2421/4/11) |
| Company | Roche |
| Complainant | Anonymous, non-contactable NHS employee |
| Product | Pegasys (peginterferon alfa-2a) |
| Main issue | Alleged conflict of interest (representative married to hepatitis C CNS at hospital in territory), plus bonuses/reward trip and speaker fees |
| Clauses considered | Clauses 2, 9.1, 15.2, 15.7 and 20.1 |
| Decision | No breach of the Code |
| Panel notes | Concerns about perception/COI; 2010 incentive payment “on the limits of acceptability”; insufficient evidence on balance of probabilities |
| Complaint received | 18 July 2011 |
| Case completed | 17 August 2011 |
| Appeal | No appeal |
| Sanctions | None |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.